Most cited papers from JMI Laboratories

JMI Laboratories

What are the most cited papers from JMI Laboratories?

The most cited paper from JMI Laboratories is "Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses" (Shawn R. Lockhart, Kizee A. Etienne, Snigdha Vallabhaneni et al., 2016), with 1,713 citations. Next come "Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016" (853) and "Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection" (810).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 171 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses Shawn R. Lockhart, Kizee A. Etienne, Snigdha Vallabhaneni et al. · Clinical Infectious Diseases Open access	14 Oct 2016	1,713
2	Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 Michael A. Pfaller, Daniel J. Diekema, John D. Turnidge et al. · Open Forum Infectious Diseases Open access	Mar 2019	853
3	Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection Mariana Castanheira, Patricia J. Simner, Patricia A. Bradford · JAC-Antimicrobial Resistance Open access	8 Jun 2021	810
4	Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations Barbara Dudley Alexander, Melissa D. Johnson, Christopher D. Pfeiffer et al. · Clinical Infectious Diseases Open access	13 Mar 2013	786
5	CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests Romney M. Humphries, Jane E. Ambler, Stephanie L. Mitchell et al. · Journal of Clinical Microbiology Open access	19 Jan 2018	785
6	Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia Ronald N. Jones · Clinical Infectious Diseases	2 Jul 2010	734
7	10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America Helen W. Boucher, George H. Talbot, Daniel K. Benjamin et al. · Clinical Infectious Diseases Open access	17 Apr 2013	703
8	The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program Daniel J. Diekema, Po‐Ren Hsueh, Rodrigo Elisandro Mendes et al. · Antimicrobial Agents and Chemotherapy Open access	22 Apr 2019	665
9	Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States James R. Johnson, Brian Johnston, Connie Clabots et al. · Clinical Infectious Diseases Open access	23 Jun 2010	524
10	Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012 Michael A. Pfaller, Daniel J. Diekema · Journal of Clinical Microbiology Open access	28 Jun 2012	493
11	Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002) Douglas J. Biedenbach, Gary J. Moet, Ronald N. Jones · Diagnostic Microbiology and Infectious Disease	Sep 2004	426
12	Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008 Michael A. Pfaller, David R. Andes, Daniel J. Diekema et al. · PLoS ONE Open access	3 Jul 2014	407
13	Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000 Michael A. Pfaller, Shawn A. Messer, Richard J. Hollis et al. · Antimicrobial Agents and Chemotherapy Open access	Apr 2002	404
14	Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008 Michael A. Pfaller, Dionysios Neofytos, Daniel J. Diekema et al. · Diagnostic Microbiology and Infectious Disease	25 Oct 2012	400
15	Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998–2004) Gary J. Moet, Ronald N. Jones, Douglas J. Biedenbach et al. · Diagnostic Microbiology and Infectious Disease	24 Oct 2006	389
16	Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata Michael A. Pfaller, Mariana Castanheira, Shawn R. Lockhart et al. · Journal of Clinical Microbiology Open access	26 Jan 2012	377
17	Oxazolidinone antibiotics Daniel J. Diekema, Ronald N. Jones · The Lancet	Dec 2001	376
18	Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi Daniel J. Diekema, Shawn A. Messer, Richard J. Hollis et al. · Journal of Clinical Microbiology Open access	Aug 2003	371
19	Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 Mariana Castanheira, Lalitagauri M. Deshpande, Dilip Mathai et al. · Antimicrobial Agents and Chemotherapy Open access	28 Dec 2010	361
20	Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program Lalitagauri M. Deshpande, Thomas R. Fritsche, Gary J. Moet et al. · Diagnostic Microbiology and Infectious Disease	28 Mar 2007	345
21	Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09) Ana Cristina Gales, Ronald N. Jones, Helio Silva Sader · Journal of Antimicrobial Chemotherapy Open access	29 Jun 2011	343
22	Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000 Michael A. Pfaller, Daniel J. Diekema, Ronald N. Jones et al. · Journal of Clinical Microbiology Open access	Mar 2002	325
23	Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010) Ana Cristina Gales, Mariana Castanheira, Ronald N. Jones et al. · Diagnostic Microbiology and Infectious Disease	31 May 2012	318
24	The changing epidemiology of healthcare-associated candidemia over three decades Daniel J. Diekema, Sophie S. Arbefeville, Linda B. Boyken et al. · Diagnostic Microbiology and Infectious Disease	May 2012	318
25	Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004) Ana Cristina Gales, Ronald N. Jones, Helio Silva Sader · Clinical Microbiology and Infection Open access	14 Feb 2006	310
26	Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001) Jeffrey T. Kirby, Helio Silva Sader, Timothy Rutland Walsh et al. · Journal of Clinical Microbiology Open access	2004	284
27	Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009) Michael A. Pfaller, Shawn A. Messer, Gary J. Moet et al. · International Journal of Antimicrobial Agents	23 Apr 2011	275
28	Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice Yilmaz Emre Gençay et al. · Nature Biotechnology Open access	4 May 2023	273
29	Molecular Characterization of a β-Lactamase Gene, bla GIM-1 , Encoding a New Subclass of Metallo-β-Lactamase Mariana Castanheira, Mark Alexander Toleman, Ronald N. Jones et al. · Antimicrobial Agents and Chemotherapy Open access	24 Nov 2004	260
30	Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012 Helio Silva Sader, David J. Farrell, Robert K. Flamm et al. · International Journal of Antimicrobial Agents	7 Feb 2014	257
31	Microbiological Features of Vancomycin in the 21st Century: Minimum Inhibitory Concentration Creep, Bactericidal/Static Activity, and Applied Breakpoints to Predict Clinical Outcomes or Detect Resistant Strains Ronald N. Jones · Clinical Infectious Diseases	5 Dec 2005	255
32	Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011) Helio Silva Sader, David J. Farrell, Robert K. Flamm et al. · Diagnostic Microbiology and Infectious Disease	6 Dec 2013	242
33	Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009 Michael A. Pfaller, Gary J. Moet, Shawn A. Messer et al. · Antimicrobial Agents and Chemotherapy Open access	30 Nov 2010	239
34	Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance Michael A. Pfaller, Shawn A. Messer, Leah N. Woosley et al. · Journal of Clinical Microbiology Open access	30 May 2013	239
35	In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp Michael A. Pfaller, Shawn A. Messer, Richard J. Hollis et al. · Antimicrobial Agents and Chemotherapy Open access	Jun 2002	232
36	First Report of cfr -Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States Rodrigo Elisandro Mendes, Lalitagauri M. Deshpande, Mariana Castanheira et al. · Antimicrobial Agents and Chemotherapy Open access	8 Apr 2008	231
37	Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) Ana Cristina Gales, Harald Seifert, Deniz Gür et al. · Open Forum Infectious Diseases Open access	Mar 2019	230
38	Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009) Michael A. Pfaller, Gary J. Moet, Shawn A. Messer et al. · Journal of Clinical Microbiology Open access	11 Nov 2010	229
39	Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms Rodrigo Elisandro Mendes, Lalitagauri M. Deshpande, Ronald N. Jones · Drug Resistance Updates	Apr 2014	227
40	Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program Daniel J. Diekema, Michael A. Pfaller, Dee Shortridge et al. · Open Forum Infectious Diseases Open access	Mar 2019	225
41	The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012 Nkechi E. Azie, Dionysios Neofytos, Michael A. Pfaller et al. · Diagnostic Microbiology and Infectious Disease	10 Jul 2012	224
42	Global Emergence of Trimethoprim/Sulfamethoxazole Resistance inStenotrophomonas maltophiliaMediated by Acquisition ofsulGenes Mark Alexander Toleman, Peter M. Bennett, David M. Bennett et al. · Emerging infectious diseases Open access	Apr 2007	219
43	Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries Mariana Castanheira, Lalitagauri M. Deshpande, Anthony M de L Costello et al. · Journal of Antimicrobial Chemotherapy	5 Mar 2014	212
44	Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent? Ana Espinel‐Ingroff et al. · Antimicrobial Agents and Chemotherapy Open access	10 Sep 2013	211
45	Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012) David J. Farrell, Robert K. Flamm, Helio Silva Sader et al. · Antimicrobial Agents and Chemotherapy Open access	7 Oct 2013	203
46	Acute Uncomplicated Cystitis in an Era of Increasing Antibiotic Resistance: A Proposed Approach to Empirical Therapy Thomas M. Hooton, Rachel E.J. Besser, Betsy Foxman et al. · Clinical Infectious Diseases	21 Jun 2004	202
47	Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex Mariana Castanheira, Rodrigo Elisandro Mendes, Ana Cristina Gales · Clinical Infectious Diseases Open access	7 Mar 2023	199
48	Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008) Paul R. Rhomberg, Ronald N. Jones · Diagnostic Microbiology and Infectious Disease	16 Oct 2009	198
49	In vitroantimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria Akinobu Ito, Naoki Kohira, Samuel K. Bouchillon et al. · Journal of Antimicrobial Chemotherapy	7 Dec 2015	192
50	Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001) Jennifer M Streit, Ronald N. Jones, Helio Silva Sader et al. · International Journal of Antimicrobial Agents	20 Jul 2004	192

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.